Home » Tenders » Americas » USA » Notice of Intent to Sole Source-Evaluating the Effect of Obesity on the Pharmacokinetics... Tender

Notice of Intent to Sole Source-Evaluating the Effect of Obesity on the Pharmacokinetics... Tender

Download Documents

HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Notice of Intent to Sole Source-Evaluating the Effect of Obesity on the Pharmacokinetics and Pharmacodynamics. The project location is USA and the tender is closing on 25 Jun 2024. The tender notice number is FDA6182024, while the TOT Ref Number is 102960572. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Notice of Intent to Sole Source-Evaluating the Effect of Obesity on the Pharmacokinetics and Pharmacodynamics

Deadline : 25 Jun 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 102960572

Document Ref. No. : FDA6182024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Description

The Food and Drug Administration (FDA) intends to award a Sole Source Firm Fixed Price contract order to University of North Carolina at Chapel Hill, 301 Pharmacy Lane, CB 7355, Chapel Hill, NC 27599-7355.

In accordance with FAR Part 6.302-1 (a) (2)(ii) which states” Only one responsible source and no other supplies or services will satisfy agency requirement”.

The purpose of this notice is to inform the public that the Food and Drug Administration (FDA) anticipates issuing a Firm Fixed Price contract.

MINIMUM REQUIREMENTS:

See Attached Statement of Work

This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement.

Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.

It is anticipated that an award will be issued to University of North Carolina at Capital Hill within approximately ten (10) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.

Response Date: June 25, 2024, by 3.00PM EST. Please email responses to Hilda Aryeh -hilda.aryeh@fda.hhs.gov.
Active Contract Opportunity Notice ID FDA6182024 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier FOOD AND DRUG ADMINISTRATION Office FDA OFFICE OF ACQ GRANT SVCS
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jun 19, 2024 08:15 am EDT
Original Response Date: Jun 25, 2024 03:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Jul 10, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: AJ11 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance: USA